Abstract
OBJECTIVE: One of the major factors influencing length of stay for patients with community-acquired pneumonia is the timing of conversion from intravenous to oral antibiotics. We measured physician attitudes and beliefs about the antibiotic switch decision and assessed physician characteristics associated with practice beliefs.
DESIGN: Written survey assessing attitudes about the antibiotic conversion decision.
SETTING: Seven teaching and non-teaching hospitals in Pittsburgh, Pa.
PARTICIPANTS: Three hundred forty-five generalist and specialist attending physicians who manage pneumonia in 7 hospitals.
MEASUREMENTS AND RESULTS: Factors rated as “very important” to the antibiotic conversion decision were: absence of suppurative infection (93%), ability to maintain oral intake (79%), respiratory rate at baseline (64%), no positive blood cultures (63%), normal temperature (62%), oxygenation at baseline (55%), and mental status at baseline (50%). The median thresholds at which physicians believed a typical patient could be converted to oral therapy were: temperature ≤100°F (37.8°C), respiratory rate ≤20 breaths/minute, heart rate ≤100 beats/minute, systolic blood pressure ≥100 mm Hg, and room air oxygen saturation ≥90%. Fiftyeight percent of physicians felt that “patients should be afebrile for 24 hours before conversion to oral antibiotics,” and 19% said, “patients should receive a standard duration of intravenous antibiotics.” In univariate analyses, pulmonary and infectious diseases physicians were the most predisposed towards early conversion to oral antibiotics, and other medical specialists were the least predisposed, with generalists being intermediate (P<.019). In multivariate analyses, practice beliefs were associated with age, inpatient care activities, attitudes about guidelines, and agreeableness on a personality inventory scale.
CONCLUSIONS: Physicians believed that patients could be switched to oral antibiotics once vital signs and mental status had stabilized and oral intake was possible. However, there was considerable variation in several antibiotic practice beliefs. Guidelines and pathways to streamline antibiotic therapy should include educational strategies to address some of these differences in attitudes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agency for Health Care Policy and Research. National Inpatient Statistics, 1996. Vol. 99-0034;1999.
Lave JR, Lin CC, Fine MJ, et al. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med. 1999;20:189–97.
Burns LR, Wholey DR. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care. 1991;29:251–71.
Cleary PD, Geenfield S, Mulley AG, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA. 1991;266:73–9.
McCormick D, Fine MJ, Coley CM, et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med. 1999;107:5–12.
Fine MJ, Singer DE, Phelps AL, et al. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care. 1993;31:371–80.
Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998;279:1452–7.
Fine MJ, Medsger AR, Stone RA, et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 1997;157:47–56.
Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis. 1998;26:811–38.
Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1993;148:1418–26.
Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18:501–13.
Jackson DN. Jackson Personality Inventory Manual. Goshen, NY: Research Psychologists Press; 1975.
Goldberg LR. The development of markers for the big five factor structure. Psychol Assess. 1992;4:26–42.
Tunis SR, Hayward RS, Wilson MC, et al. Internists’ attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:956–63.
Zeger SL, Lian KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121–30.
Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134–41.
Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.
Jay SJ, Johnson WGJ, Pierce AK. The radiographic resolution of Streptococcus pneumoniae pneumonia. N Engl J Med. 1975;293:798–801.
MacFarlane JT, Miller AC, Smith WH, et al. Comparative radiographic features of community-acquired Legionnaires’ disease, pneumococcal pneumonia, Mycoplasma pneuemoniae and psittacosis. Thorax. 1984;36:369–72.
Weingarten SR, Riedinger MS, Hobson P, et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med. 1996;153:1110–5.
Rhew DC, Hackner D, Henderson L, et al. The clinical benefit of inhospital observation in ‘low-risk’ pneumonia patients after conversion from parenteral to oral antimicrobial therapy. Chest. 1998;113:142–6.
Dunn AS, Peterson KL, Schechter CB, et al. The utility of an inhospital observation period after discontinuing intravenous antibiotics. Am J Med. 1999;106:6–10.
Ramirez JA, Srinath L, Ahkee S, et al. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med. 1995;155:1273–6.
Siegel RE, Halpern NA, Almenoff PL, et al. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest. 1996;110:965–71.
Ramirez JA, Vargas S, Ritter GW, et al. Early switch from intravenous to oral antibiotics and early hospital discharge. Arch Intern Med. 1999;159:2449–54.
Switzer GE, Halm EA, Goldman J, et al. Physician familiarity with and use of national and local pneumonia practice guidelines. J Gen Intern Med. 1999;14(suppl):124.
Halm EA, Causino N, Blumenthal D. Is gatekeeping better than traditional care? A survey of physicians’ attitudes. JAMA. 1997;278:1677–81.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported in part by the Agency for Healthcare Research and Quality and by National Institute of Allergy and Immunology grant #R01 HS08282-02. Drs. Fine and Halm were supported in part by the Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Program.
Rights and permissions
About this article
Cite this article
Halm, E.A., Switzer, G.E., Mittman, B.S. et al. What factors influence physicians’ decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia?. J GEN INTERN MED 16, 599–605 (2001). https://doi.org/10.1046/j.1525-1497.2001.016009599.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2001.016009599.x